Adamis Pharmaceuticals Corp Business Finance Contracts & Agreements
120 Contracts & Agreements
- Credit Agreements (3 contracts)
- Debenture Agreements (1)
- Escrow Agreements (1)
- Exchange Agreements (1)
- Guarantee Agreements (3)
- Joinder Agreements (1)
- Loan Agreements (13)
- Note Agreements (17)
- Purchase Agreements (18)
- Registration Rights Agreements (7)
- Release Agreements (2)
- Security Agreements (3)
- Share Agreements (2)
- Stock Agreements (19)
- Subscription Agreements (1)
- Underwriting Agreements (6)
- Waiver Agreements (1)
- Warrant Agreements (21)
- COMMONSTOCK PURCHASE WARRANT ADAMISPHARMACEUTICALS CORPORATION (Filed With SEC on November 14, 2023)
- Form of Inducement Stock Option Award Agreement (Filed With SEC on October 19, 2023)
- Inducement Stock Option Award Agreement dated as of October 16, 2023 (Filed With SEC on October 19, 2023)
- Securities Purchase Agreement (Filed With SEC on August 3, 2023)
- Purchase and Sale Agreement (Filed With SEC on July 24, 2023)
- Form of Securities Purchase Agreement (Filed With SEC on July 13, 2023)
- Form of Warrant Agency Agreement (Filed With SEC on July 13, 2023)
- Form of Pre-Funded Warrant (Filed With SEC on July 13, 2023)
- Form of Common Stock Warrant (Filed With SEC on July 13, 2023)
- DMK 2016 Stock Plan (Filed With SEC on May 26, 2023)
- Securities Purchase Agreement dated March 14, 2023 (Filed With SEC on May 15, 2023)
- Prefunded Common Stock Purchase Warrant dated March 16, 2023 (Filed With SEC on May 15, 2023)
- Common Stock Purchase Warrant dated March 16, 2023 (Filed With SEC on May 15, 2023)
- Form of Securities Purchase Agreement (Filed With SEC on March 14, 2023)
- Form of Prefunded Common Stock Purchase Warrant (Filed With SEC on March 14, 2023)
- Form of Common Stock Purchase Warrant (Filed With SEC on March 14, 2023)
- Registration Rights Agreement, dated July 5, 2022, between Adamis Pharmaceuticals Corporation and the parties thereto (Filed With SEC on July 6, 2022)
- Securities Purchase Agreement, dated July 5, 2022, between Adamis Pharmaceuticals Corporation and the parties thereto (Filed With SEC on July 6, 2022)
- Common Stock Purchase Warrant dated July 5, 2022 (Filed With SEC on July 6, 2022)
- Press Release issued May 26, 2022 (Filed With SEC on May 26, 2022)
- Press Release dated October 4, 2021 (Filed With SEC on October 4, 2021)
- Asset Purchase Agreement effective as of July 30, 2021, by and among the Registrant, US Compounding, Inc. and Fagron Compounding Services, LLC (Filed With SEC on August 5, 2021)
- Promissory Note dated March 15, 2021 (Filed With SEC on April 15, 2021)
- Description of the Registrant's Capital Stock (Filed With SEC on April 15, 2021)
- Underwriting Agreement, dated January 29, 2021, by and between Adamis Pharmaceuticals Corporation and Raymond James & Associates, Inc., as representative of the underwriters named... (Filed With SEC on January 29, 2021)
- Underwriting Agreement, dated September 18, 2020, by and between Adamis Pharmaceuticals Corporation and Raymond James & Associates, Inc., as representative of the underwriters... (Filed With SEC on September 18, 2020)
- Amended Promissory Note between the Company and Arvest Bank (Filed With SEC on September 15, 2020)
- August 2020 Amendment to Loan Amendment and Assumption Agreement between the Company and Arvest Bank (Filed With SEC on September 15, 2020)
- Description of the Registrants Common Stock (Filed With SEC on June 22, 2020)
- Promissory Note date April 10, 2020 (Filed With SEC on April 15, 2020)
- DESCRIPTION OF CAPITAL STOCK (Filed With SEC on March 30, 2020)
- Form of Securities Purchase Agreement (Filed With SEC on February 21, 2020)
- Form of Warrant (Filed With SEC on February 21, 2020)
- Form of Stock Appreciation Rights Agreement for Non-Employee Directors (Filed With SEC on November 12, 2019)
- Form of Warrant dated August 5, 2019 (Filed With SEC on November 12, 2019)
- Form of Warrant (Filed With SEC on August 1, 2019)
- Underwriting Agreement, dated August 1, 2019, by and between Adamis Pharmaceuticals Corporation and Raymond James & Associates, Inc., as representative of the underwriters named... (Filed With SEC on August 1, 2019)
- June 2018 Amendment to Loan and Security Agreement (Filed With SEC on August 9, 2018)
- Underwriting Agreement (Filed With SEC on August 2, 2018)
- March 2018 Amended and Restated Line of Credit Promissory Note (Filed With SEC on March 16, 2018)
